GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (OSL:LYTIX) » Definitions » Dividend-Payout-to-FFO

Lytix Biopharma AS (OSL:LYTIX) Dividend-Payout-to-FFO


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401, and LTX-315 are in the pipeline.